Titan Medical Inc. Signs an Agreement With Cadence Device Inc. for Manufacturing of Instruments for the SPORT(TM) Surgical System

TORONTO, ON--(Marketwired - November 30, 2015) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) today announced that it has signed an agreement with Cadence Device, Inc., a wholly-owned subsidiary of Cadence, Inc., ("Cadence"). Under the terms of the agreement, Cadence will develop, manufacture and manage the supply chain, sterilization and distribution for multi-articulating robotic instruments for use with Titan's SPORT™ Surgical System.

John Hargrove, Chairman and CEO of Titan Medical Inc., commented, "We are very excited to partner with Cadence, a leading contract manufacturer in the medical field. Their proven level of expertise will be key for the development and manufacture of innovative multi-articulating instruments, which are important for Titan's success as we move closer to the commercialization of the SPORT Surgical System."

Alan Connor, President and CEO of Cadence stated, "We are pleased to partner with Titan to help design and build the instrumentation for the SPORT Surgical System. We are very impressed with what Titan is preparing to bring to the market and look forward to playing a key role in the continued advancement of this novel robotic system."

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's Single Port Orifice Robotic Technology, SPORT™ Surgical System, currently under development, is comprised of a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT™ Surgical System is being designed to expand robotic surgery into both simple and complex areas of surgical specialties and procedures that are currently under-serviced. It is also being designed to allow surgeons to perform procedures within small- to medium-size surgical spaces for general abdominal, gynecologic, and urologic indications. For more information, visit the Company's website at www.titanmedicalinc.com.

About Cadence Device, Inc.

Cadence Device, Inc. is a part of Cadence, Inc., a leading contract manufacturer of advanced products for medical device OEMs. Cadence develops new products that others cannot, builds processes that others will not, and delivers outcomes that simply make the world work better. Cadence enables improved product performance and economics for new medical devices. Advanced plastics and metals capabilities coupled with finished device assembly make a turn-key impact that matters. Cadence employs nearly 500 people worldwide with headquarters in Staunton, VA and other locations in Massachusetts, Pennsylvania, Rhode Island, Wisconsin and a near-shore location in the Dominican Republic. To find out more visit the Company's web site at www.cadenceinc.com.

Forward-Looking Statements

This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors " section of the Company's Annual Information Form dated March 31, 2015 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.